Interaction between vitamin D receptor and vitamin D ligands: Two-dimensional alanine scanning mutational analysis

Chemistry and Biology

Volumn 10, Issue 3, 2003, Pages 261-270

  Choi, Mihwa ^a   Yamamoto, Keiko ^a   Itoh, Toshimasa ^a   Makishima, Makoto ^b   Mangelsdorf, David J ^c   Moras, Dino ^d   DeLuca, Hector F ^e   Yamada, Sachiko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0037351986     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(03)00050-4     Document Type: Article

References (32)

1. Kragballe K. Psoriasis and other skin diseases. Feldman D., Glorieux F.H., Pike J.W. Vitamin D. 1997;Academic Press, San Diego. 1213-1225.pp.
2. 3. 1990 version J. Bone Miner. Metab. 8:1990;1-9.
3. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
4. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P.et al. The nuclear receptor superfamily. the second decade Cell. 83:1995;835-839.
5. Wurtz J.M., Bourguet W., Renaud J.P., Vivat V., Chambon P., Moras D., Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3:1996;87-94.
6. Yamada S., Yamamoto K., Masuno H. Structure-function analysis of vitamin D and VDR model. Curr. Pharm. Des. 6:2000;733-748.
7. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell. 5:2000;173-179.
8. 3 analogs with restricted side chain conformation J. Org. Chem. 58:1993;2530-2537.
9. 3 responsible for binding to the receptor. Bioorg. Med. Chem. Lett. 5:1995;979-984.
10. 3 and its 20-epimer. compounds for study of the three-dimensional structure of vitamin D responsible for binding to the receptor J. Med. Chem. 39:1996;2727-2737.
11. Yamada S., Yamamoto K., Masuno H., Ohta M. Conformation-function relationship of vitamin D. conformational analysis predicts potential side chain structure J. Med. Chem. 41:1998;1467-1475.
12. Yamamoto K., Ooizumi H., Umesono K., Verstuyf A., Bouillon R., DeLuca H.F., Shinki T., Suda T., Yamada S. Three-dimensional structure-function relationship of vitamin D. side chain location and various activities Bioorg. Med. Chem. Lett. 9:1999;1041-1046.
13. 3 analogues. Chem. Pharm. Bull. (Tokyo). 34:1986;4410-4413.
14. 3 (ED-71), preventive and therapeutic effects on bone mineral loss in ovariectomized rats. Bioorg. Med. Chem. Lett. 3:1993;1815-1819.
15. 3 analogues. a novel class of potent regulators of cell growth and immune responses Biochem. Pharmacol. 42:1991;1569-1575.
16. 3 compounds of high biological activity. synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues J. Med. Chem. 41:1998;4662-4674.
17. Makishima M., Lu T.T., Xie W., Whitfield G.K., Domoto H., Evans R.M., Haussler M.R., Mangelsdorf D.J. Vitamin D receptor as an intestinal bile acid sensor. Science. 296:2002;1313-1316.
18. Yamamoto K., Masuno H., Choi M., Nakashima K., Taga T., Ooizumi H., Umesono K., Sicinska W., VanHooke J., DeLuca H.F.et al. Three-dimensional modeling of and ligand docking to vitamin D receptor ligand-binding domain. Proc. Natl. Acad. Sci. USA. 97:2000;1467-1472.
19. Choi M., Yamamoto K., Masuno H., Nakashima K., Taga T., Yamada S. Ligand recognition by the vitamin D receptor. Bioorg. Med. Chem. 9:2001;1721-1730.
20. 3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc. Natl. Acad. Sci. USA. 87:1990;9995-9999.
21. Geller D.S., Farhi A., Pinkerton N., Fradley M., Moritz M., Spitzer A., Meinke G., Tsai F.T.F., Sigler P.B., Lifton R.P. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science. 289:2000;119-123.
22. Tocchini-Valentini G., Rochel N., Wurtz J.M., Mitschler A., Moras D. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc. Natl. Acad. Sci. USA. 98:2001;5491-5496.
23. 3 selectively induces bone formation. Proc. Natl. Acad. Sci. USA. 99:2002;13487-13491.
24. Narisawa T., Magadia N.E., Weisburger J.H., Wynder E.L. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N′-nitro-N-nitrosoguanidine in rats. J. Natl. Cancer Inst. 53:1974;1093-1097.
25. Rarey M., Kramer B., Lengauer T., Klebe G. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 261:1996;470-489.
26. Kramer B., Rarey M., Lengauer T. Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins. 37:1999;228-241.
27. Rochel N., Tocchini-Valentini G., Egea P.F., Juntunen K., Garnier J.-M., Vihko P., Moras D. Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor. Eur. J. Biochem. 268:2001;971-979.
28. Watkins R.E., Wisely G.B., Moore L.B., Collins J.L., Lambert M.H., Williams S.P., Willson T.M., Kliewer S.A., Redinbo M.R. The human nuclear xenobiotic receptor PXR. structural determinants of directed promiscuity Science. 292:2001;2329-2333.
29. Yamada, S., and Yamamoto, K. September 1998. WO9839292.
30. Sicinski, R.R., Glagett-Dame, M., Plum, L., Deluca, H.F., and Gowlugari, S. August 2002. U.S. patent 6440953.
31. 3 receptors. Cell. 65:1991;1255-1266.
32. 3. Generation by a preparation enriched in a. 64:1983;. 000-dalton J. Biol. Chem. 258, 1289-1296.